Search

July 29, 2020

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clindamycin Phosphate Gel USP, 1% (Twice-A-Day) in 30 g and 60 g tubes a generic version of reference listed drug CLEOCIN T® (Clindamycin Phosphate) 1% Topical Gel.. For more updates, please feel free to email us info@solaris-pharma.com

69 views0 comments

Recent Posts

See All

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clindamycin Phosphate Gel USP

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Fluocinolone Acetonide Oil, 0